Related Experiment Video
Updated: Aug 18, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Arterial hypertension and cardiovascular risk in patients with nephropathy]
1U.O. Nefrologia-Malpighi, Policlinico S.Orsola-Malpighi, Bologna -Italy. Santoro@orsola-malpighi.med.unibo.it
Insights
Arterial hypertension is linked to cardiovascular diseases, but optimal blood pressure targets in renal insufficiency patients remain unclear. Emerging research suggests differential pressure may be a better indicator of vascular damage than traditional metrics.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Context:
- Arterial hypertension is a major risk factor for cardiovascular diseases (CVDs) in the general population.
- Patients with renal insufficiency face additional vascular damage factors linked to uremia, including oxidative stress and chronic inflammation, accelerating atherosclerosis.
- Optimal blood pressure targets in renal insufficiency patients are debated, with some studies questioning the hypertension-cardiovascular mortality link and highlighting hypotension risks.
Purpose:
- To explore the complex relationship between arterial pressure and cardiovascular outcomes in patients with renal insufficiency.
- To investigate the limitations of traditional blood pressure markers (systolic, diastolic, mean) in assessing vascular damage.
- To introduce and evaluate the concept of differential pressure as a more reliable index of vascular damage and arterial compliance.
Summary:
- While hypertension is a known CVD risk factor, its role in renal insufficiency is complex, with hypotension potentially posing a greater prognostic risk.
- Uremic factors like oxidative stress and inflammation contribute to early atherosclerosis in renal patients.
- Differential pressure, reflecting arterial wall rigidity and compliance, is proposed as a superior marker for vascular damage compared to traditional blood pressure measurements.
Impact:
- Highlights the need for reassessment of blood pressure targets in renal insufficiency patients.
- Suggests differential pressure may offer a more accurate assessment of cardiovascular risk and vascular damage.
- Informs clinical practice regarding the challenges and potential new strategies for managing hypertension in dialysis patients.
Abstract:
In the general population, there is a very close link between arterial hypertension and cardiovascular diseases (CVDs); hypertension is the most important predictive factor for coronary disease. In the patient with renal insufficiency, along with the classical factors behind vascular damage, there are those linked to uremia such as oxidative stress, hyperhomocysteinemia, ADMA and chronic microinflammation, responsible for the process of early atherosclerosis. Nevertheless, many questions remain unanswered concerning the optimum pressure target, both in terms of which arterial pressure could be more indicative of organ damage and the ideal pressure range for the patient. On the one hand, recent studies in populations with advanced renal insufficiency have cast doubts on the close relationship between hypertension and cardiovascular mortality, attributing a more unfavorable prognostic weight to hypotension than to hypertension. On the other hand, a new concept concerning arterial pressure has been developing over recent years, i.e. differential pressure, which is supposed to represent a vascular damage index, in terms of wall rigidity; and therefore, arterial compliance, which is more reliable, complete and dynamic as compared to the traditional pressure markers such as systolic, diastolic and mean blood pressure (BP). This renders our attempt to control the risk factors as somewhat limited, with the sole control of systolic BP and diastolic BP in absolute terms. Control that to judge from the various studies published to date, appears to be far from easy to implement in clinical practice, and above all in dialysis.
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
01:29Hypertension II: Pathophysiology
01:28Diabetic Nephropathy
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
01:23Atherosclerosis IV: Nursing Management
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System